CDC Announces Shortage of Nirsevimab, Used for RSV

Nirsevimab, a monoclonal antibody used to protect infants from respiratory syncytial virus (RSV), is in limited supply, according to a CDC announcement.

Related Keywords

Alaska ,United States ,American , ,Advisory Committee On Immunization Practices ,American Academy Of Pediatrics ,Immunization Practices ,American Indian ,Alaska Native ,American Academy ,Nirsevimab ,Cdc ,Rsv ,Infants ,Monoclonal Antibody ,